223 related articles for article (PubMed ID: 19389076)
1. Prion protein oligomers in Creutzfeldt-Jakob disease detected by gel-filtration centrifuge columns.
Minaki H; Sasaki K; Honda H; Iwaki T
Neuropathology; 2009 Oct; 29(5):536-42. PubMed ID: 19389076
[TBL] [Abstract][Full Text] [Related]
2. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
3. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease.
Freixes M; Puig B; Rodríguez A; Torrejón-Escribano B; Blanco R; Ferrer I
Acta Neuropathol; 2004 Oct; 108(4):295-301. PubMed ID: 15235804
[TBL] [Abstract][Full Text] [Related]
4. Advances in the detection of prion protein in peripheral tissues of variant Creutzfeldt-Jakob disease patients using paraffin-embedded tissue blotting.
Ritchie DL; Head MW; Ironside JW
Neuropathol Appl Neurobiol; 2004 Aug; 30(4):360-8. PubMed ID: 15305981
[TBL] [Abstract][Full Text] [Related]
5. Adenosine A1 receptor protein levels and activity is increased in the cerebral cortex in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP mice.
Rodríguez A; Martín M; Albasanz JL; Barrachina M; Espinosa JC; Torres JM; Ferrer I
J Neuropathol Exp Neurol; 2006 Oct; 65(10):964-75. PubMed ID: 17021401
[TBL] [Abstract][Full Text] [Related]
6. Protease-resistant PrP and PrP oligomers in the brain in human prion diseases after intraventricular pentosan polysulfate infusion.
Honda H; Sasaki K; Minaki H; Masui K; Suzuki SO; Doh-Ura K; Iwaki T
Neuropathology; 2012 Apr; 32(2):124-32. PubMed ID: 21801238
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of water channel aquaporin 1 and aquaporin 4 in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP transgenic mice.
Rodríguez A; Pérez-Gracia E; Espinosa JC; Pumarola M; Torres JM; Ferrer I
Acta Neuropathol; 2006 Nov; 112(5):573-85. PubMed ID: 16871401
[TBL] [Abstract][Full Text] [Related]
8. Prominent stress response of Purkinje cells in Creutzfeldt-Jakob disease.
Kovács GG; Kurucz I; Budka H; Adori C; Müller F; Acs P; Klöppel S; Schätzl HM; Mayer RJ; László L
Neurobiol Dis; 2001 Oct; 8(5):881-9. PubMed ID: 11592855
[TBL] [Abstract][Full Text] [Related]
9. Creutzfeldt-Jakob disease and inclusion body myositis: abundant disease-associated prion protein in muscle.
Kovacs GG; Lindeck-Pozza E; Chimelli L; Araújo AQ; Gabbai AA; Ströbel T; Glatzel M; Aguzzi A; Budka H
Ann Neurol; 2004 Jan; 55(1):121-5. PubMed ID: 14705121
[TBL] [Abstract][Full Text] [Related]
10. Plaque-type deposition of prion protein in the damaged white matter of sporadic Creutzfeldt-Jakob disease MM1 patients.
Kobayashi A; Arima K; Ogawa M; Murata M; Fukuda T; Kitamoto T
Acta Neuropathol; 2008 Nov; 116(5):561-6. PubMed ID: 18751990
[TBL] [Abstract][Full Text] [Related]
11. A traceback phenomenon can reveal the origin of prion infection.
Kobayashi A; Asano M; Mohri S; Kitamoto T
Neuropathology; 2009 Oct; 29(5):619-24. PubMed ID: 19659941
[TBL] [Abstract][Full Text] [Related]
12. Neuronal phosphorylated RNA-dependent protein kinase in Creutzfeldt-Jakob disease.
Paquet C; Bose A; Polivka M; Peoc'h K; Brouland JP; Keohane C; Hugon J; Gray F
J Neuropathol Exp Neurol; 2009 Feb; 68(2):190-8. PubMed ID: 19151623
[TBL] [Abstract][Full Text] [Related]
13. Amyloid plaques in Creutzfeldt-Jakob disease stain with prion protein antibodies.
Kitamoto T; Tateishi J; Tashima T; Takeshita I; Barry RA; DeArmond SJ; Prusiner SB
Ann Neurol; 1986 Aug; 20(2):204-8. PubMed ID: 3092727
[TBL] [Abstract][Full Text] [Related]
14. An autopsy case of Creutzfeldt-Jakob disease with a V180I mutation of the PrP gene and Alzheimer-type pathology.
Yoshida H; Terada S; Ishizu H; Ikeda K; Hayabara T; Ikeda K; Deguchi K; Touge T; Kitamoto T; Kuroda S
Neuropathology; 2010 Apr; 30(2):159-64. PubMed ID: 19703264
[TBL] [Abstract][Full Text] [Related]
15. Loss of cerebellar granule neurons is associated with punctate but not with large focal deposits of prion protein in Creutzfeldt-Jakob disease.
Faucheux BA; Privat N; Brandel JP; Sazdovitch V; Laplanche JL; Maurage CA; Hauw JJ; Haïk S
J Neuropathol Exp Neurol; 2009 Aug; 68(8):892-901. PubMed ID: 19606064
[TBL] [Abstract][Full Text] [Related]
16. Classification of sporadic Creutzfeldt-Jakob disease revisited.
Cali I; Castellani R; Yuan J; Al-Shekhlee A; Cohen ML; Xiao X; Moleres FJ; Parchi P; Zou WQ; Gambetti P
Brain; 2006 Sep; 129(Pt 9):2266-77. PubMed ID: 16923954
[TBL] [Abstract][Full Text] [Related]
17. Creutzfeldt-Jakob disease in a patient with an R208H mutation of the prion protein gene (PRNP) and a 17-kDa prion protein fragment.
Roeber S; Krebs B; Neumann M; Windl O; Zerr I; Grasbon-Frodl EM; Kretzschmar HA
Acta Neuropathol; 2005 Apr; 109(4):443-8. PubMed ID: 15739100
[TBL] [Abstract][Full Text] [Related]
18. Distribution of intraneuronal immunoreactivity for the prion protein in human prion diseases.
Kovacs GG; Voigtländer T; Hainfellner JA; Budka H
Acta Neuropathol; 2002 Sep; 104(3):320-6. PubMed ID: 12172919
[TBL] [Abstract][Full Text] [Related]
19. Creutzfeldt-Jakob disease (CJD) of a short duration with prion protein (PrP) plaques.
Liberski PP; Kwieciński H; Barcikowska M; Mirecka B; Kulczycki J; Kida E; Brown P; Gajdusek DC
Patol Pol; 1991; 42(4):115-8. PubMed ID: 1845486
[TBL] [Abstract][Full Text] [Related]
20. A Fluorescent Oligothiophene-Bis-Triazine ligand interacts with PrP fibrils and detects SDS-resistant oligomers in human prion diseases.
Imberdis T; Ayrolles-Torro A; Duarte Rodrigues A; Torrent J; Alvarez-Martinez MT; Kovacs GG; Verdier JM; Robitzer M; Perrier V
Mol Neurodegener; 2016 Jan; 11():11. PubMed ID: 26809712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
